Iovance Biotherapeutics annual revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2022
2023
2024
2025
Iovance Biotherapeutics Revenue Growth & History (IOVA)
Iovance Biotherapeutics reported $263.5M in revenue for fiscal 2025, an increase of 60.60% from the previous fiscal year.
View full Iovance Biotherapeutics company overviewIovance Biotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $263.5M | $99.4M | +60.60% |
| 2024 | 2024-12-31 | $164.1M | $162.9M | +13698.99% |
| 2023 | 2023-12-31 | $1.2M | $1.2M | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | $0 | — |
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | $0 | — |
| 2013 | 2013-12-31 | $0 | $0 | — |
| 2012 | 2012-12-31 | $0 | $0 | — |
| 2011 | 2011-12-31 | $0 | $0 | — |
| 2010 | 2010-12-31 | $0 | $0 | — |
| 2009 | 2009-12-31 | $0 | — | — |
Iovance Biotherapeutics quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q3.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $99.3M | $39.4M | +65.65% |
| Q1 2026 | 2026-03-31 | $71.4M | $22.1M | +44.82% |
| Q4 2025 | 2025-12-31 | $86.8M | $13.1M | +17.74% |
| Q3 2025 | 2025-09-30 | $67.5M | $8.9M | +15.20% |
| Q2 2025 | 2025-06-30 | $60.0M | $28.8M | +92.73% |
| Q1 2025 | 2025-03-31 | $49.3M | $48.6M | +6798.46% |
| Q4 2024 | 2024-12-31 | $73.7M | — | — |
| Q3 2024 | 2024-09-30 | $58.6M | $58.1M | +12385.07% |
| Q2 2024 | 2024-06-30 | $31.1M | $30.9M | +12969.75% |
| Q1 2024 | 2024-03-31 | $715,000 | — | — |
| Q3 2023 | 2023-09-30 | $469,000 | — | — |
| Q2 2023 | 2023-06-30 | $238,000 | — | — |
| Q1 2019 | 2019-03-31 | $0 | $0 | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | $0 | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | $0 | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $0 | $0 | — |
| Q3 2015 | 2015-09-30 | $0 | $0 | — |
| Q2 2015 | 2015-06-30 | $0 | $0 | — |
| Q1 2015 | 2015-03-31 | $0 | $0 | — |
| Q4 2014 | 2014-12-31 | $0 | $0 | — |
| Q3 2014 | 2014-09-30 | $0 | $0 | — |
| Q2 2014 | 2014-06-30 | $0 | $0 | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q4 2013 | 2013-12-31 | $0 | — | — |
| Q3 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | — | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q1 2012 | 2012-03-31 | $0 | $0 | — |
| Q4 2011 | 2011-12-31 | $0 | — | — |
| Q3 2011 | 2011-09-30 | $0 | $0 | — |
| Q2 2011 | 2011-06-30 | $0 | $0 | — |
| Q1 2011 | 2011-03-31 | $0 | — | — |
| Q3 2010 | 2010-09-30 | $0 | — | — |
| Q2 2010 | 2010-06-30 | $0 | — | — |
Iovance Biotherapeutics revenue growth trends
Iovance Biotherapeutics's latest reported quarter, Q2 2026, generated $99.3M in revenue, an increase of 65.65% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Iovance Biotherapeutics source filings ↗